Discover our impact all over the world.

Numbers displayed on the map are a representation of the activity in each country. Once you use the filter selections below, you will have the opportunity to explore projects and faculty in each country.

Projects + Faculty = Activity Number



Projects 643
Countries 131
Faculty 435
Health Topics 141

Filter from the selections below

Clear All Filters

A Phase 2a, Randomized, Double-Blind, Placebo-Controlled, Clinical Trial To Evaluate The Safety And Immunogenicity Of The ID93 + GLA-SE Vaccine In HIV Uninfected Adult TB Patients After Treatment Completion

The purpose of this study is to evaluate the safety and immunogenicity of ID93 + GLA-SE vaccine when administered to HIV uninfected adult pulmonary TB patients in either two doses 56 days apart or three doses 28 days apart, following successful completion of TB treatment with confirmed bacteriologic cure, in preparation for a future Phase 2b prevention of TB recurrence trial in the same population.

Active Dates 
09/01/2015 to 03/31/2017
Faculty Involved